JPMorgan Chase & Co. Initiates Coverage on Immunome (NASDAQ:IMNM)

JPMorgan Chase & Co. assumed coverage on shares of Immunome (NASDAQ:IMNM – Free Report) in a research note published on Tuesday, Marketbeat reports. The firm issued an overweight rating and a $24.00 price objective on the stock. IMNM has been the subject of several other reports. Guggenheim initiated coverage on Immunome in a report on […]

Related Keywords

Leerink Partnrs ,Td Asset Management Inc ,Immunome Company Profile ,Jpmorgan Chase Co ,Immunome Inc ,Cerity Partners ,Free Report ,Get Free Report ,Partners Management ,Management Inc ,Immunome Daily ,Simmunome ,Nasdaq Imnm ,Imnm ,Medical ,Initiated Coverage ,